Bruce Keyt - 23 Nov 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Scientific Officer
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
23 Nov 2022
Transactions value $
-$18,918
Form type
4
Date filed
28 Nov 2022, 19:29
Previous filing
06 Oct 2022
Next filing
16 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Sale -$12.8K -600 -1.52% $21.38 38.9K 23 Nov 2022 Direct F1, F2
transaction IGMS Common Stock Sale -$6.09K -277 -0.71% $21.99 38.6K 23 Nov 2022 Direct F1, F3
holding IGMS Common Stock 1.01K 23 Nov 2022 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $20.74 to $21.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $21.74 to $22.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 The shares are held directly by the reporting person's spouse.